Results 291 to 300 of about 621,864 (351)

Intranasal spike and nucleoprotein fusion protein-based vaccine provides cross-protection and reduced transmission against SARS-CoV-2 variants. [PDF]

NPJ Vaccines
Lakhrif Z, Poupée-Beaugé A, Boursin F, Ducournau C, Lantier L, Moiré N, Carpentier R, Rossignol C, Maquart M, Jospin F, Merat L, Caul-Futy M, Yazdanpanah Y, Bouakane A, Riou M, Touzé A, Eléouët JF, Richard CA, Helle F, Le Poder S, Klonjkowski B, Meunier N, Zientara S, Paul S, Mévélec MN, Aubrey N, Epardaud M, Dimier-Poisson I.   +27 more
europepmc   +1 more source

Biomimetic Nanovaccine Integrating Dendritic Cell Exosomes with Tumor Cell Membranes for Sustained Prophylaxis Against Glioblastoma

Advanced Functional Materials, EarlyView.
We have developed DEX/GM, an all‐natural, personalizable hybrid vaccine designed by coating dendritic cell‐derived exosomes (DEX) onto tumor cell membranes (GM) for sustained prophylaxis against glioblastoma (GBM). ABSTRACT Glioblastoma (GBM), one of the most aggressive and lethal brain tumors, remains incurable with a poor clinical prognosis.
Shanshan Li, Dongya Zhang, Shiyu Wang, Changhe Pang, Meng Zheng, Bingyang Shi, Yan Zou   +6 more
wiley   +1 more source

A multi-epitope subunit vaccine providing broad cross-protection against diverse serotypes of Streptococcus suis. [PDF]

NPJ Vaccines
Liu J, Zhang Z, Pu W, Pan X, Li P, Bai Q, Liang S, Li C, Yu Y, Yao H, Ma J.   +10 more
europepmc   +1 more source

Integration of Low‐Voltage Nanoscale MoS2 Memristors on CMOS Microchips

Advanced Functional Materials, EarlyView.
This article presents the first monolithic integration of nanoscale MoS2‐based memristors into the back‐end‐of‐line of foundry‐fabricated CMOS microchips in a one‐transistor‐one‐resistor (1T1R) architecture. The MoS2‐based 1T1R cells exhibit forming‐free, nonvolatile resistive switching with ultra‐low operating voltages, low cycle‐to‐cycle variability ...
Jimin Lee, Sofía Cruces, Xiaohua Liu, Yang Chen, Vasilis A. Maroufidis, Janghyun Jo, Lukas Völkel, Dennis Braun, Michael Möller, Leon Brackmann, Holger Kalisch, Michael Heuken, Andrei Vescan, Rafal E. Dunin‐Borkowski, Joachim Mayer, Stefan Wiefels, Max C. Lemme   +16 more
wiley   +1 more source

Lineage 7 Porcine Reproductive and Respiratory Syndrome Vaccine Demonstrates Cross-Protection Against Lineage 1 and Lineage 3 Strains. [PDF]

Vaccines (Basel)
Chiu HJ, Chang SW, Lin H, Chuang YC, Kuo KL, Lin CH, Chiou MT, Lin CN.   +7 more
europepmc   +1 more source

Evaluation of cross-protection of a reduced-dose PRRS MLV vaccine against the NADC30-like PRRSV challenge. [PDF]

Front Vet Sci
Liu J, Yan X, Wu W, Li Y, Xing S, Zhao S, Huang X, Zhao Q, Wen Y, Cao S, Du S, Yan Q, Zeng N.   +12 more
europepmc   +1 more source

Enhancing cross-protection against influenza by heterologous sequential immunization with mRNA LNP and protein nanoparticle vaccines. [PDF]

Nat Commun
Dong C, Zhu W, Wei L, Kim JK, Ma Y, Kang SM, Wang BZ.   +6 more
europepmc   +1 more source

Efficacy evaluation of a bivalent subunit vaccine against epidemic PEDV heterologous strains with low cross-protection. [PDF]

J Virol
Song X, Li Y, Wang C, Zhao Y, Yang S, Guo R, Hu M, Sun M, Zhang G, Li Y, Wang Y, Liu S, Shen Y, Li C, Zhang X, Li J, Fan B, Li B.   +17 more
europepmc   +1 more source

Reinforcing Creditor Protection: The Imperative for The Cross-Border Insolvency Regulation

Daniel Hendrawan, Bernadette M. Waluyo, Johannes Gunawan   +2 more
openalex   +2 more sources

A Study of Cross-Protection between <i>Eimeria maxima</i> Immunovariants. [PDF]

Pathogens
Jenkins MC, O'Brien CN, Parker CC, Tucker MS.   +3 more
europepmc   +1 more source